Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of a single dose of 750 U
of Dysport compared to placebo for the improvement in the daily incontinence episode
frequency for each administration mode in subjects suffering from neurogenic detrusor
overactivity following spinal cord injury or multiple sclerosis.
Phase:
Phase 2
Details
Lead Sponsor:
Ipsen
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA